Challenge of the Unknown: How Can We Improve Clinical Outcomes in Cancer of Unknown Primary?-Reference-Cited by-同舟云学术

Challenge of the Unknown: How Can We Improve Clinical Outcomes in Cancer of Unknown Primary?

Published:2019-08-10 Issue:23 Volume:37 Page:2089-2090
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Conway Alicia-Marie¹,Mitchell Claire¹,Cook Natalie¹

Affiliation:

1. Alicia-Marie Conway, MD, The Christie NHS Foundation Trust, Manchester, United Kingdom, The University of Manchester, Manchester, United Kingdom, and Cancer Research UK Manchester Institute, Manchester, United Kingdom; Claire Mitchell, MD, PhD, The Christie NHS Foundation Trust, Manchester, United Kingdom; and Natalie Cook, MD, PhD, The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.00449

Reference9 articles.

1. Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the ‘U’ out of ‘CUP’

2. Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute

3. Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)

4. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

5. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary;Nature Medicine;2023-08

2. Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patients;2022-12-26

3. Site-speciﬁc chemotherapy based on gene expression proﬁling versus empirical chemotherapy for people with cancer of unknown primary site;Cochrane Database of Systematic Reviews;2021-09-27

4. Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches;Frontiers in Cell and Developmental Biology;2021-06-10

5. Sentinel node theory helps tracking of primary lesions of cancers of unknown primary;BMC Cancer;2020-07-09